These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24989329)

  • 1. Assessing liver fibrosis: comparison of arterial enhancement fraction and diffusion-weighted imaging.
    Bonekamp D; Bonekamp S; Ou HY; Torbenson MS; Corona-Villalobos CP; Mezey E; Kamel IR
    J Magn Reson Imaging; 2014 Nov; 40(5):1137-46. PubMed ID: 24989329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ.
    Do RK; Chandarana H; Felker E; Hajdu CH; Babb JS; Kim D; Taouli B
    AJR Am J Roentgenol; 2010 Sep; 195(3):671-6. PubMed ID: 20729445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.
    Sandrasegaran K; Akisik FM; Lin C; Tahir B; Rajan J; Saxena R; Aisen AM
    AJR Am J Roentgenol; 2009 Dec; 193(6):1556-60. PubMed ID: 19933647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
    Eminler AT; Ayyildiz T; Irak K; Kiyici M; Gurel S; Dolar E; Gulten M; Nak SG
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1361-6. PubMed ID: 26352130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography.
    Ichikawa S; Motosugi U; Morisaka H; Sano K; Ichikawa T; Enomoto N; Matsuda M; Fujii H; Onishi H
    J Magn Reson Imaging; 2015 Jul; 42(1):204-10. PubMed ID: 25223820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
    Deghady A; Abdou A; El-Neanaey WA; Diab I
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.
    Watanabe H; Kanematsu M; Goshima S; Kondo H; Onozuka M; Moriyama N; Bae KT
    Radiology; 2011 Apr; 259(1):142-50. PubMed ID: 21248234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis.
    Hsieh YY; Tung SY; Lee IL; Lee K; Shen CH; Wei KL; Chang TS; Chuang CS; Wu CS; Lin YH
    Chang Gung Med J; 2009; 32(6):614-22. PubMed ID: 20035640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of acoustic radiation force impulse/serum noninvasive markers for fibrosis prediction in liver transplant.
    Pinto J; Matos H; Nobre S; Cipriano MA; Marques M; Pereira JM; Gonçalves I; Noruegas MJ
    J Pediatr Gastroenterol Nutr; 2014 Mar; 58(3):382-6. PubMed ID: 24164902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI arterial enhancement fraction in hepatic fibrosis and cirrhosis.
    Ou HY; Bonekamp S; Bonekamp D; Corona-Villalobos CP; Torbenson MS; Geiger B; Kamel IR
    AJR Am J Roentgenol; 2013 Oct; 201(4):W596-602. PubMed ID: 24059398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Tesla magnetic resonance elastography for hepatic fibrosis: comparison with diffusion-weighted imaging and gadoxetic acid-enhanced magnetic resonance imaging.
    Park HS; Kim YJ; Yu MH; Choe WH; Jung SI; Jeon HJ
    World J Gastroenterol; 2014 Dec; 20(46):17558-67. PubMed ID: 25516671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of aspartate aminotransferase to platelet ratio for diagnosis of liver fibrosis and prediction of postoperative prognosis in infants with biliary atresia.
    Yang LY; Fu J; Peng XF; Pang SY; Gao KK; Chen ZR; He LJ; Wen Z; Wang H; Li L; Wang FH; Yu JK; Xu Y; Gong ST; Xia HM; Liu HY
    World J Gastroenterol; 2015 May; 21(19):5893-900. PubMed ID: 26019453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging liver fibrosis in chronic hepatitis B with T
    Yang L; Ding Y; Rao S; Chen C; Wu L; Sheng R; Fu C; Zeng M
    J Magn Reson Imaging; 2017 Apr; 45(4):1186-1194. PubMed ID: 27563840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study on clinical and pathological changes of liver fibrosis with diffusion-weighted imaging].
    Zhou ML; Yan FH; Xu PJ; Chen CZ; Shen JZ; Li RC; Ji Y; Shi JY
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1757-61. PubMed ID: 19862980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index.
    Motosugi U; Ichikawa T; Oguri M; Sano K; Sou H; Muhi A; Matsuda M; Fujii H; Enomoto N; Araki T
    Magn Reson Imaging; 2011 Oct; 29(8):1047-52. PubMed ID: 21775085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis--a multiparametric approach.
    Feier D; Balassy C; Bastati N; Fragner R; Wrba F; Ba-Ssalamah A
    Eur Radiol; 2016 Feb; 26(2):539-46. PubMed ID: 25991488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.